Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592

Dexamethasone in Hospitalized Patients with Covid-19

The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254

Remdesivir for the Treatment of Covid-19 — Final Report

Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267

Factors associated with COVID-19-related death using OpenSAFELY

Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32661-1 · Cited by 4,616

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481

Attributes and predictors of long COVID

Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., Pujol, J. C., Klaser, K., Antonelli, M., Canas, L. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01292-y · Cited by 2,707

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

Cummings, M. J., Baldwin, M. R., Abrams, D. C., Jacobson, S. D., Meyer, B. J., Balough, E. M., Aaron, J. G., Claassen, J., Rabbani, L. E., Hastie, J. M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31189-2 · Cited by 2,245

Female gender is associated with long COVID syndrome: a prospective cohort study

Bai, F., Tomasoni, D., Falcinella, C., Barbanotti, D., Castoldi, R., Mulè, G., Augello, M., Mondatore, D., Allegrini, M., Cona, A., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.11.002 · Cited by 644

Immune cell-mediated features of non-alcoholic steatohepatitis

Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573

Metformin: Is it a drug for all reasons and diseases?

Triggle, C. R., Mohammed, I., Bshesh, K., Marei, I., Ye, K., Ding, H., MacDonald, R. S., Hollenberg, M. D., & Hill, M. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155223 · Cited by 300

Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021

Zhou, X., Chen, Q., Yang, W., Zuluaga, M., Targher, G., Byrne, C. D., Valenti, L. V. C., Luo, F., Katsouras, C. S., Thaher, O., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102848 · Cited by 269

Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine

Pellini, R., Venuti, A., Pimpinelli, F., Abril, E., Blandino, G., Campo, F., Conti, L., VIRGILIO, A. D., Marco, F. D., Domenico, E. G. D., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100928 · Cited by 237

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

Reiterer, M., Rajan, M., Gómez-Banoy, N., Lau, J. D., Gómez-Escobar, L. G., Ma, L., Gilani, A., Alvarez-Mulett, S. L., Sholle, E., Chandar, V., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.009 · Cited by 235

Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?

Islam, H., Chamberlain, T. C., Mui, A., & Little, J. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.677008 · Cited by 191

Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication

Chu, J., Xing, C., Du, Y., Duan, T., Liu, S., Zhang, P., Cheng, C., Henley, J. E., Liu, X., Chen, Q., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00479-4 · Cited by 138

Impact of COVID-19 on the Endocrine System: A Mini-review

Clarke, S. A., Abbara, A., & Dhillo, W. S. (2021) · Endocrinology · doi:10.1210/endocr/bqab203 · Cited by 116

COVID-19–Induced New-Onset Diabetes: Trends and Technologies

Metwally, A. A., Mehta, P., Johnson, B. S., Nagarjuna, A., & Snyder, M. P. (2021) · Diabetes · doi:10.2337/dbi21-0029 · Cited by 110

Diabetes and COVID-19: The past, the present, and the future

Pranata, R., Henrina, J., Raffaello, W. M., Lawrensia, S., & Huang, I. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154814 · Cited by 109

Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza

Zhang, V., Fisher, M. C., Hou, W., Zhang, L., & Duong, T. Q. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21174 · Cited by 100

Post-acute sequelae of COVID-19: A metabolic perspective

Scherer, P. E., Kirwan, J. P., & Rosen, C. J. (2022) · eLife · doi:10.7554/elife.78200 · Cited by 92

Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota

Li, S., Yang, S., Zhou, Y., Disoma, C., Dong, Z., Du, A., Zhang, Y., Chen, Y., Huang, W., Chen, J., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.712081 · Cited by 80

Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection

Norouzi, M., Norouzi, S., Ruggiero, A. D., Khan, M. S., Myers, S., Kavanagh, K., & Vemuri, R. (2021) · Microorganisms · doi:10.3390/microorganisms9061211 · Cited by 70

Coronavirus Infection and Cholesterol Metabolism

Dai, J., Wang, H., Liao, Y., Tan, L., Sun, Y., Song, C., Liu, W., Qiu, X., & Ding, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.791267 · Cited by 68

SARS-CoV-2 infects adipose tissue in a fat depot- and viral lineage-dependent manner

Saccon, T. D., Mousovich‐Neto, F., Ludwig, R. G., Carregari, V. C., Souza, A. B. D. A., dos Passos, A. S. C., Martini, M. C., Barbosa, P. P., de Souza, G. F., Muraro, S. P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33218-8 · Cited by 70

Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza

Lu, J., Wilson, J., Hou, W., Fleysher, R., Herold, B. C., Herold, K. C., & Duong, T. Q. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104487 · Cited by 64

Profiling single cancer cell metabolism via high-content SRS imaging with chemical sparsity

Tan, Y., Lin, H., & Cheng, J. (2023) · Science Advances · doi:10.1126/sciadv.adg6061 · Cited by 65

The central role of mitochondrial fitness on antiviral defenses: An advocacy for physical activity during the COVID-19 pandemic

Burtscher, J., Burtscher, M., & Millet, G. P. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101976 · Cited by 67

Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans

Zickler, M., Stanelle‐Bertram, S., Ehret, S., Heinrich, F., Lange, P., Schaumburg, B., Kouassi, N. M., Beck, S., Jaeckstein, M. Y., Mann, O., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.002 · Cited by 63

Metabolic Reprogramming in COVID-19

Shen, T., & Wang, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111475 · Cited by 61

Life as Aftermath: Social Theory for an Age of Anthropogenic Biology

Landecker, H. L. (2024) · Science Technology & Human Values · doi:10.1177/01622439241233946 · Cited by 68

Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection

Dey, S., Murmu, N., Mondal, T., Saha, I., Chatterjee, S., Manna, R., Haldar, S., Dash, S. K., Sarkar, T. R., & Giri, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113801 · Cited by 58

The Importance of Metabolism for Immune Homeostasis in Allergic Diseases

Rodríguez‐Coira, J., Villaseñor, A., Izquierdo, E., Huang, M., Barker‐Tejeda, T. C., Radzikowska, U., Sokołowska, M., & Barber, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692004 · Cited by 58

Limited extent and consequences of pancreatic SARS-CoV-2 infection

van der Heide, V., Jangra, S., Cohen, P., Rathnasinghe, R., Aslam, S., Aydillo, T., Geanon, D., Handler, D., Kelley, G., Lee, B. H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110508 · Cited by 56

A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19

Logette, E., Lorin, C., Favreau, C., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M., Delattre, É., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.695139 · Cited by 58

The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico

Woolcott, O. O., & Castilla-Bancayán, J. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-88014-z · Cited by 54

Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis

Bradley, S., Banach, M., Alvarado, N., Smokovski, I., & Bhaskar, S. M. M. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13243 · Cited by 52

Diabetes Mellitus, Energy Metabolism, and COVID-19

Conte, C., Cipponeri, E., & Roden, M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad032 · Cited by 51

Adipose Tissue-Endothelial Cell Interactions in Obesity-Induced Endothelial Dysfunction

Li, M., Qian, M., Kyler, K., & Xu, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.681581 · Cited by 50

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism

Kim, T. H., Hong, D.-G., & Yang, Y. M. (2021) · Biomedicines · doi:10.3390/biomedicines9121903 · Cited by 57

Myricetin ameliorated prediabetes via immunomodulation and gut microbiota interaction

Yang, L., Gao, Y., Gong, J., Wang, H., Farag, M. A. F., Simal‐Gándara, J., Zhao, Y., Nie, S., & Xiao, J. (2022) · Food Frontiers · doi:10.1002/fft2.152 · Cited by 47

Mechanisms contributing to adverse outcomes of COVID-19 in obesity

Sudhakar, M., Beaula, W. S., Meiyazhagan, G., & Parvathi, V. D. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04356-w · Cited by 50

Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role?

Guglielmi, V., Colangeli, L., D’Adamo, M., & Sbraccia, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063183 · Cited by 45

The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications

Shraim, B. A., Moursi, M. O., Benter, I. F., Habib, A. M., & Akhtar, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.701390 · Cited by 43

COVID‐19 metabolism: Mechanisms and therapeutic targets

Wang, T., Cao, Y., Zhang, H., Wang, Z., Man, C. H., Yang, Y., Chen, L., Xu, S., Yan, X., Zheng, Q., et al. (2022) · MedComm · doi:10.1002/mco2.157 · Cited by 42

COVID-19: Diabetes Perspective—Pathophysiology and Management

Dallavalasa, S., Tulimilli, S. V., Janhavi, P., Ramachandra, R., Madhunapantula, S. V., & Veeranna, R. P. (2023) · Pathogens · doi:10.3390/pathogens12020184 · Cited by 45

Hyperglycemia-triggered lipid peroxidation destabilizes STAT4 and impairs anti-viral Th1 responses in type 2 diabetes

Gray, V., Chen, W., Tan, R. J. Y., Teo, J. M. N., Huang, Z., Fong, C. H.-Y., Law, T. W. H., Ye, Z., Yuan, S., Bao, X., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.10.004 · Cited by 43

Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19

Zhu, B., Wei, X., Narasimhan, H., Qian, W. G., Zhang, R., Cheon, I. S., Wu, Y., Li, C., Jones, R. G., Kaplan, M. H., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adf0348 · Cited by 39

7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19

Ghzaiel, I., Sassi, K., Zarrouk, A., Nury, T., Ksila, M., Leoni, V., Bouhaouala‐Zahar, B., Hammami, S. O., Hammami, M., Mackrill, J. J., et al. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105939 · Cited by 40

The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois

Udoakang, A. J., Zune, A. L. D., Tapela, K., Nganyewo, N. N., Olisaka, F. N., Anyigba, C. A., Tawiah-Eshun, S., Owusu, I. A., Paemka, L., Awandare, G. A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104828 · Cited by 40

New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic

Carvajal, J. J., García-Castillo, V., Cuellar, S. V., Campillay-Véliz, C. P., Salazar‐Ardiles, C., Avellaneda, A. M., Muñoz, C. A., Retamal-Díaz, A. R., Bueno, S. M., González, P. A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1363572 · Cited by 42

SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis

Zhu, J., Wang, G., Huang, X., Lee, H., Lee, J., Yang, P., van de Leemput, J., Huang, W., Kane, M. A., Yang, P., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03986-6 · Cited by 37

Intestinal Damage in COVID-19: SARS-CoV-2 Infection and Intestinal Thrombosis

Wu, X., Jing, H., Wang, C., Wang, Y., Zuo, N., Jiang, T., Novakovic, V. A., & Shi, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.860931 · Cited by 35

Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review

Brooks, D., Schulman‐Rosenbaum, R., Griff, M., Lester, J., & Wang, C. C. L. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.07.014 · Cited by 41

Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19

Muskiet, F. A. J., Carrera‐Bastos, P., Pruimboom, L., Lucía, A., & Furman, D. (2022) · Nutrients · doi:10.3390/nu14071388 · Cited by 34

Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes?

Atkinson, M. A., & Powers, A. C. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00087-5 · Cited by 33

Stress Hyperglycemia, Diabetes Mellitus and COVID-19 Infection: Risk Factors, Clinical Outcomes and Post-Discharge Implications

Gerganova, A., Assyov, Y. S., & Kamenov, Z. A. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.826006 · Cited by 34

Detection of COVID-19-related biomarkers by electrochemical biosensors and potential for diagnosis, prognosis, and prediction of the course of the disease in the context of personalized medicine

Vásquez, V., & Orozco, J. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04237-7 · Cited by 32

Visceral fat inflammation and fat embolism are associated with lung’s lipidic hyaline membranes in subjects with COVID-19

Colleluori, G., Graciotti, L., Pesaresi, M., Vincenzo, A. D., Perugini, J., Mercurio, E. D., Caucci, S., Bagnarelli, P., Zingaretti, C. M., Nisoli, E., et al. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01071-w · Cited by 32

Editorial: Obesity, metabolic phenotypes and COVID-19

Sanoudou, D., Hill, M. A., Belanger, M. J., Arao, K., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2021.155121 · Cited by 30

Not so sweet and simple: impacts of SARS-CoV-2 on the β cell

Ibrahim, S., Monaco, G. S. F., & Sims, E. K. (2021) · Islets · doi:10.1080/19382014.2021.1909970 · Cited by 30

GRP78, a Novel Host Factor for SARS-CoV-2: The Emerging Roles in COVID-19 Related to Metabolic Risk Factors

Shin, J., Toyoda, S., Fukuhara, A., & Shimomura, I. (2022) · Biomedicines · doi:10.3390/biomedicines10081995 · Cited by 32

Metabolism of NK cells during viral infections

Osuna-Espinoza, K. Y., & Rosas-Taraco, A. G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1064101 · Cited by 30

Viruses and amyloids - a vicious liaison

Hammarström, P., & Nyström, S. (2023) · Prion · doi:10.1080/19336896.2023.2194212 · Cited by 29

Obesity as a clinical predictor for severe manifestation of dengue: a systematic review and meta-analysis

Chen, C., Chiu, Y.-Y., Chen, Y., Huang, C., Wang, W., Chen, Y., & Lin, C. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08481-9 · Cited by 27

An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity

Gómez‐Zorita, S., Milton‐Laskibar, I., Arellano-García, L., González, M. A., & Portillo, M. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157975 · Cited by 27

Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccines

Lee, C., Gray, V., Teo, J. M. N., Tam, A. R., Fong, C. H.-Y., Lui, D. T. W., Pang, P., Chan, K. H., Hung, I. F., Tan, K. C. B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1018393 · Cited by 26

Infection with SARS-CoV-2 can cause pancreatic impairment

Deng, W., Bao, L., Song, Z., Zhang, L., Yü, P., Xu, Y., Wang, J., Zhao, W., Zhang, X., Han, Y., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01796-2 · Cited by 27

Development and Prospects of Furin Inhibitors for Therapeutic Applications

Ivachtchenko, A. V., Khvat, A. V., & Shkil, D. O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179199 · Cited by 25

Delirium in hospitalized COVID-19 patients: Predictors and implications for patient outcome

Wilke, V., Sulyok, M., Stefanou, M., Richter, V., Bender, B., Ernemann, U., Ziemann, U., Malek, N. P., Kienzle, K., Klein, C., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278214 · Cited by 24

SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders

Cinquegrani, G., Spigoni, V., Iannozzi, N. T., Parello, V., Bonadonna, R. C., & Dei, A. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09693-y · Cited by 24

COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study

Smati, S., Tramunt, B., Wargny, M., Gourdy, P., Hadjadj, S., & Cariou, B. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01452-5 · Cited by 27

The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?

Czupryniak, L., Dicker, D., Lehmann, R., Prázný, M., & Schernthaner, G. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01389-1 · Cited by 23

Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry

Stefan, N., Sippel, K., Heni, M., Fritsche, A., Wagner, R. J., Jakob, C. E. M., Preissl, H. T., von Werder, A., Khodamoradi, Y., Borgmann, S., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.875430 · Cited by 25

COVID-19 associated diabetes mellitus: A review

Gavkare, A. M., Nanaware, N. L., Rayate, A. S., Mumbre, S. S., & Nagoba, B. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i9.729 · Cited by 23

Fucoxanthin extract ameliorates obesity associated with modulation of bile acid metabolism and gut microbiota in high-fat-diet fed mice

Hao, J., Zhang, J., & Wu, T. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03256-z · Cited by 23

ACE2 polymorphisms impact COVID-19 severity in obese patients

Jalaleddine, N., Bouzid, A., Hachim, M. Y., Sharif‐Askari, N. S., Mahboub, B. H., Senok, A. C., Halwani, R., Hamoudi, R., & Heialy, S. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-26072-7 · Cited by 22

Repurposing Metformin for Vascular Disease

Triggle, C. R., Marei, I., Ye, K., Ding, H., Anderson, T. J., Hollenberg, M. D., & Hill, M. A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220729154615 · Cited by 22

RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications

Ke, D., Zhang, Z., Liu, J., Chen, P., Dai, Y., Sun, X., Chu, Y., & Li, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1274654 · Cited by 22

The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2

Thomas, G., Couture, F., & Kwiatkowska, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073435 · Cited by 21

Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study

Tramunt, B., Smati, S., Coudol, S., Wargny, M., Pichelin, M., Guyomarch, B., Al‐Salameh, A., Amadou, C., Barraud, S., Bigot‐Corbel, E., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0068 · Cited by 19

Drosophila, a powerful model to study virus-host interactions and pathogenicity in the fight against SARS-CoV-2

van de Leemput, J., & Han, Z. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00621-5 · Cited by 20

Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan

Angeles, M. R., Dona, S. W. A., Nguyen, D., Le, L. K., & Hensher, M. (2022) · BMC Public Health · doi:10.1186/s12889-022-13169-x · Cited by 18

Increased morbidity of obese mice infected with mouse-adapted SARS-CoV-2

Zhang, Y., Zhang, Z., Zhang, H., Li, X., Li, J., Zhang, Q., Liu, J., Li, Q., Deng, C., Shi, Z., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00305-x · Cited by 17

The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication

Baker, P. J., Bohrer, A. C., Castro, E., Amaral, E. P., Snow-Smith, M., Torres-Juárez, F., Gould, S. T., Queiroz, A. T. L., Fukutani, E. R., Jordan, C. M., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adp7951 · Cited by 17

Time-varying association of acute and post-acute COVID-19 with new-onset diabetes mellitus among hospitalized and non-hospitalized patients

Reges, O., Test, T., Hoshen, M., Cicurel, A., Saliba, W., Greenland, P., Dicker, D., & Lavie, G. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003052 · Cited by 17

Obesity-compromised immunity in post-COVID-19 condition: a critical control point of chronicity

Jang, S.-W., Hong, W., & Moon, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1433531 · Cited by 17

SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients

Ji, N., Zhang, M., Ren, L., Wang, Y., Hu, B., Xiang, J., Gong, Y., Wu, C., Qu, G., Ding, W., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2059400 · Cited by 17

Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark

Johannesen, C. K., Rezahosseini, O., Gybel‐Brask, M., Kristensen, J. H., Hasselbalch, R. B., Pries‐Heje, M. M., Nielsen, P. B., Knudsen, A. D., Fogh, K., Norsk, J. B., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00904-21 · Cited by 16

Low muscle mass and high visceral fat mass predict mortality in patients hospitalized with moderate-to-severe COVID-19: a prospective study

Beltrão, F. E. D. L., Beltrão, D. C. D. A., Carvalhal, G., Beltrão, F. N. D. L., de Aquino, I. M., Brito, T. D. S., Paulino, B. C., Aires, E., Viegas, D., Hecht, F., et al. (2022) · Endocrine Connections · doi:10.1530/ec-22-0290 · Cited by 17

SARS-CoV-2 fires up inflammation in adipose tissue

Stefan, N. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00778-0 · Cited by 16

Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells

Tonon, F., Candido, R., Toffoli, B., Tommasi, E. D., Cortello, T., Fabris, B., & Bernardi, S. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.01.029 · Cited by 15

The Endocrine Adipose Organ: A System Playing a Central Role in COVID-19

Cinti, F., & Cinti, S. (2022) · Cells · doi:10.3390/cells11132109 · Cited by 17

Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study

Benderra, M., Aparicio, A., Leblanc, J., Wassermann, D., Kempf, E., Galula, G., Bernaux, M., Canellas, A., Moreau, T., Bellamine, A., et al. (2021) · Cancers · doi:10.3390/cancers13194749 · Cited by 15

SARS-CoV-2 infection induces persistent adipose tissue damage in aged golden Syrian hamsters

Bogard, G., Barthelemy, J., Hantute-Ghesquier, A., Sencio, V., Rodrigues, P. B., Séron, K., Robil, C., Flourens, A., Pinet, F., Eberlé, D., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05574-w · Cited by 16

Leptin deficiency-caused behavioral change – A comparative analysis using EthoVision and DeepLabCut

Bühler, D., Guerra, N. P., Müller, L., Wolkenhauer, O., Düffer, M., Vollmar, B., Kuhla, A., & Wolfien, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1052079 · Cited by 15

Assessment of the Immune Response in Patients with Insulin Resistance, Obesity, and Diabetes to COVID-19 Vaccination

Warpechowski, J. J., Leszczyńska, P., Juchnicka, D., Olichwier, A. J., Szczerbiński, Ł., & Kretowski, A. J. (2023) · Vaccines · doi:10.3390/vaccines11071203 · Cited by 17

Mechanisms and pathophysiology of SARS-CoV-2 infection of the adipose tissue

Moser, J., Emous, M., Heeringa, P., & Rodenhuis‐Zybert, I. A. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.08.010 · Cited by 16

Factors associated with weight gain during COVID-19 pandemic: A global study

Huang, J., Chan, S. C., Ko, S., Wang, H., Yuan, J., Xu, W., Zheng, Z., Xue, H., Zhang, L., Jiang, J. Y., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284283 · Cited by 16

Preserved C ‐peptide in survivors of COVID ‐19: Post hoc analysis

Clarke, S. A., Phylactou, M., Patel, B., Mills, E., Muzi, B., Izzi‐Engbeaya, C. N., Khoo, B. C. E., Meeran, K. M., Comninos, A. N., Abbara, A., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14608 · Cited by 14

Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents

Infante, M., Padilla, N., Alejandro, R., Caprio, M., Della‐Morte, D., Fabbri, A., & Ricordi, C. (2022) · Medicina · doi:10.3390/medicina58050571 · Cited by 17

Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation

Ahmad, W., & Shabbiri, K. (2022) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-021-00092-7 · Cited by 13

The Role of SARS-CoV-2 Nucleocapsid Protein in Host Inflammation

Cao, Y., Wang, Y., Huang, D.-G., & Tan, Y. (2025) · Viruses · doi:10.3390/v17081046 · Cited by 12

Sustained metabolic dysregulation and the emergence of diabetes: associations between HbA1c and metabolic syndrome components in Tunisian diabetic and nondiabetic groups

Wisniewski, A., DeLouize, A. M., Walker, T., Chatterji, S., Naidoo, N., Kowal, P. R., & Snodgrass, J. J. (2024) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-024-00365-4 · Cited by 13

Clinically Informative Micrornas for SARS-CoV-2 Infection

Ergün, S., Sankaranarayanan, R., & Petrović, N. (2023) · Epigenomics · doi:10.2217/epi-2023-0179 · Cited by 12

New practice in semaglutide on type-2 diabetes and obesity: clinical evidence and expectation

Liu, Y., & Luo, X. (2022) · Frontiers of Medicine · doi:10.1007/s11684-021-0873-2 · Cited by 13

COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3?

Kujundžić, R. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084309 · Cited by 12

Dissecting inflammation in the immunemetabolomic era

Ogger, P. P., & Murray, P. J. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05715-8 · Cited by 13

Pathophysiologic Processes, Correlates and Comorbidities of Obesity and Type 2 Diabetes Evidenced in the SARS-CoV-2/COVID-19 Pandemic

Chukwuma, C. (2025) · Mathews Journal of Diabetes & Obesity · doi:10.30654/mjdo.10023 · Cited by 2

UNDERSTANDING THE PATHOPHYSIOLOGIC MECHANISMS AND INTERPLAY BETWEEN SARS-CoV-2 /COVID-19, OBESITY AND DIABETES WITH INCURSIONS INTO THE POST-PANDEMIC ERA

Chrysanthus, C. S. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.18045918

INSIGHTS FOR CLINICAL INTERVENTIONS AND PUBLIC HEALTH STRATEGIES IN OBESITY AND DIABETES ASSOCIATED WITH THE COVID-19

Sr*, D. C. C. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.17909208

Diabetes Mellitus, Energy Metabolism, and COVID-19

Conte, C., Cipponeri, E., & Roden, M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad032 · Cited by 51

Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle

Holly, J. M. P., Biernacka, K. M., Maskell, N. A., & Perks, C. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.582870 · Cited by 56